We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

209 hedge funds and large institutions have $1.46B invested in Dynavax Technologies in 2022 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 65 increasing their positions, 60 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more call options, than puts

Call options by funds: $27.1M | Put options by funds: $12.8M

33% more capital invested

Capital invested by funds: $1.1B → $1.46B (+$361M)

16% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 37

11.58% more ownership

Funds ownership: 81.4%92.98% (+12%)

8% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 60

1% more funds holding

Funds holding: 207209 (+2)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
209
Holders Change
+2
Holders Change %
+0.97%
% of All Funds
3.52%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
43
Increased
65
Reduced
60
Closed
37
Calls
$27.1M
Puts
$12.8M
Net Calls
+$14.3M
Net Calls Change
+$9.24M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$234M +$114M +10,767,432 +138%
Federated Hermes
2
Federated Hermes
Pennsylvania
$202M -$5.47M -515,107 -3%
State Street
3
State Street
Massachusetts
$109M +$1.39M +130,695 +2%
BCLSI
4
Bain Capital Life Sciences Investors
Massachusetts
$106M
Vanguard Group
5
Vanguard Group
Pennsylvania
$101M +$23.2M +2,180,769 +37%
CC
6
Chicago Capital
Illinois
$73.6M -$136K -12,806 -0.2%
Fisher Asset Management
7
Fisher Asset Management
Washington
$54M +$8.26M +777,683 +22%
PHS
8
PFM Health Sciences
California
$47.9M
William Blair & Company
9
William Blair & Company
Illinois
$31.8M -$275K -25,922 -1%
EDRH
10
Edmond de Rothschild Holding
Switzerland
$29.2M -$1.33M -125,000 -5%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$26.2M +$929K +87,419 +4%
Goldman Sachs
12
Goldman Sachs
New York
$21.9M -$4.67M -439,503 -20%
Two Sigma Advisers
13
Two Sigma Advisers
New York
$21.2M -$408K -38,400 -2%
RSCM
14
Rock Springs Capital Management
Maryland
$21.2M +$962K +90,564 +6%
Morgan Stanley
15
Morgan Stanley
New York
$18.7M +$2.35M +221,078 +17%
N
16
Nuveen
North Carolina
$18.1M +$1.14M +106,876 +8%
Northern Trust
17
Northern Trust
Illinois
$16.6M +$1.7M +160,183 +14%
Invesco
18
Invesco
Georgia
$16.2M +$7.66M +721,133 +127%
Renaissance Technologies
19
Renaissance Technologies
New York
$15.7M +$6.68M +629,200 +101%
Two Sigma Investments
20
Two Sigma Investments
New York
$14.2M -$2.55M -240,112 -18%
WP
21
Woodline Partners
California
$13.7M +$11.5M +1,086,883 New
GLA
22
Great Lakes Advisors
Illinois
$13.2M +$10.9M +1,021,718 +3,955%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$12.5M +$6.76M +636,580 +179%
Charles Schwab
24
Charles Schwab
California
$11.7M +$268K +25,244 +3%
Pacer Advisors
25
Pacer Advisors
Pennsylvania
$11.4M +$9.66M +909,019 New

DVAX Hedge Fund Activity: Q2 2022 in Review

209 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q2 2022, worth a combined $1.46B — up 33% from $1.1B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new DVAX positions and 37 closed out — a net gain of 6 holders — while 65 added to existing stakes and 60 trimmed.

The largest buyer was BlackRock, adding an estimated $114M. The largest seller was Millennium Management, cutting an estimated $15.9M.

  • 209 institutional investors held Dynavax Technologies (DVAX) as of Q2 2022, up from 207 in Q1 2022.
  • Funds reported $1.46B of Dynavax Technologies stock for Q2 2022, up 33% quarter-over-quarter.
  • 43 funds opened new Dynavax Technologies positions in Q2 2022 and 37 closed out, a net change of +6 holders.
  • The largest Dynavax Technologies buyer in Q2 2022 was BlackRock, an estimated $114M added.
  • The largest Dynavax Technologies seller in Q2 2022 was Millennium Management, an estimated $15.9M sold.

Based on aggregated 13F filings for Q2 2022.